Safety of dermatologic medications in pregnancy and lactation: An update-Part II: Lactation.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE
    • Publication Information:
      Original Publication: St. Louis, Mo., Mosby
    • Subject Terms:
      Lactation*/drug effects ; Skin Diseases*/drug therapy ; Dermatologic Agents*/adverse effects ; Dermatologic Agents*/therapeutic use ; Pregnancy Complications*/drug therapy; Humans ; Female ; Pregnancy ; Breast Feeding
    • Abstract:
      Multiple recently approved medications have been added to our treatment armamentarium for various dermatologic conditions. Herein, we have reviewed the literature, consolidated available safety data, and offered recommendations based upon available evidence as a reference guide for clinicians treating patients for dermatologic conditions during lactation.
      Competing Interests: Conflicts of interest None disclosed.
      (Copyright © 2024 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)
    • Contributed Indexing:
      Keywords: Janus kinases; acne; antibiotic; antifungal; antihistamines; antipruritics; antiviral; atopic; biologics; breastfeeding; corticosteroid; cosmetics; dermatitis; dermatologic agents; eczema; human; infant; lactation; medication safety; milk; mother; newborn; phototherapy; psoriasis; surgery; wet nursing
    • Accession Number:
      0 (Dermatologic Agents)
    • Publication Date:
      Date Created: 20240127 Date Completed: 20240921 Latest Revision: 20240921
    • Publication Date:
      20240922
    • Accession Number:
      10.1016/j.jaad.2023.10.071
    • Accession Number:
      38280680